One of the biggest issues facing the global agriculture industry is the use of genetically modified organisms (GMOs) in crops and food products. This study compares financial performance of major GMO food companies to other industries. Findings indicate that GMO companies had an average higher return on equity but also a higher level of risk. In addition, the study presents positive and negative perspectives toward GMO foods, along with a discussion of the risks and opportunities. Agricultural studies indicate that applying GMO technology is likely the most effective way to feed many of the world's hungry. In addition, research supports the safety and nutritional benefits of GMO food products. However, concerns expressed by GMO opponents have been effective in limiting GMO acceptance by the public. Research indicates that the 2
Introduction
Use of genetically modified organisms (GMOs) in crops and food products has become one of the most controversial issues in world society. Acceptance or rejection of GMO foods will have a major impact on people's nutrition and health. Proponents of GMO foods perceive them as a solution for global problems such as climate change and world hunger. Such benefits would be particularly meaningful to people in developing countries in Africa, Asia, and Latin America. Detractors of GMO foods are concerned about potential unpredictable consequences. First sold in grocery stores in 1994, GMO foods are now sold in virtually all chain supermarkets, with the most pervasive GM foods being soy-, corn-, and wheat-based products.
This study presents an economic and financial performance analysis of major companies that are associated with GMO food products. Whether GMO foods are accepted or rejected will have a major impact on food producers, distributors, retailers, and consumers. Results from the financial performance analysis will be of interest to investors and other stakeholders regarding how these GMO food companies compare to other industries. In addition, the study presents the positive and negative perspectives toward GMO foods, along with a discussion of the risks and opportunities for GMO-connected companies.
Research questions
The objective of this study is to evaluate the financial vitality of companies associated with GMO foods. Proponents of GMO foods have expressed that there has been unwarranted and unscientific negativity expressed in the media, that the benefits of GMO foods have been unfairly overshadowed by false concerns. At the same time, detractors of GMO foods feel that there has been a lack of study of GMO foods and that more study is needed before GMO foods are widely distributed (Linnhoff et al., 2015) . The study addresses two research questions: To test the first research question, statistical tests will be used to compare the means of key financial ratios [price to earnings (P/E) ratio, profit margin, debt to equity (D/E) ratio, and return on equity (ROE) ratio] of selected GMO food companies to ratios of companies in other industries. To test the second research question, an evaluation will be made of the positive and negative views that have been expressed regarding GMOs.
Literature review
The two most common types of GMOs fall under one of the two categories: transgenic or cisgenic. As shown in Figure 1 (a), cisgenesis is a genetic modification of a recipient plant with a natural gene from a crossable, sexually compatible plant. As shown in Figure 1 (b), transgenesis is a genetic modification of a recipient plant with one or more genes from a non-plant organism, or a donor plant that is sexually incompatible with the recipient plant and would not occur in nature. As illustrated in Figure 1 (c), traditional breeding includes all plant breeding methods that do not fall under current GMO methodology (Schouten et al., 2006) . 
Source: Schouten et al. (2006) 2.1 A history of benefits and concerns Linnhoff et al. (2015) indicate that possible positive outcomes of GMOs include enhancing agricultural productivity via crops that are drought resistant and insect resistant; this, in turn would lead to reduction in world hunger, notably in developing countries. Most of the world's poorest people are located in developing countries in Africa, Asia, and Latin America. Improvements in agriculture would be especially meaningful in these locations. While there is a need for additional research on use of GMOs, there has been extensive research on agriculture in developing countries, such as regarding rehabilitation of natural resources in Ethiopia (Ebrahim, 2014) , water infrastructure in Libya (Abdudayem and Scott, 2014) , and climate change on agriculture in Nigeria (Odozi et al., 2013) . Creation of GM products can be traced back thousands of years to when Native Americans used a primitive version of genetic manipulation, referred to as selective breeding, to produce food with desirable traits. Only within the last century have plant breeders gained control at the genome level, allowing for single gene modifications (Falk et al., 2002) . The first successful GM plant was created in 1983, but it was not until 1994 that the first GM food was approved for production and resale (Batista and Oliveira, 2009) . From 2013 to 2014, the amount of GM crops produced globally increased by 6.3 million hectares to a total of 181.5 million hectares. Even with this increasing popularity, GM technology still engenders controversy.
Falk and his associate researchers observe that "food, an emotional and personal topic, combined with misunderstanding of biotechnology, sensationalized media coverage, and complex ethical and social matters have interacted to create fear in some consumers" [Falk et al., (2002 [Falk et al., ( ), p.1388 . According to the same research, when asked in a national survey how often GM plays a role in the production of processed foods, only 14% of Americans answered correctly. Lack of knowledge creates a major roadblock for the public acceptance of GM products.
Although there has been no evidence of detrimental effects from use of GM, people continue to be wary. Some critics say that the acceptance of GM technology brings with it a sub-goal of altering fundamental perceptions and values. These critics are not so worried about the potential for physical harm but the potential for damage that diminishes the "environment, human values and relationships, and intellectual property rights" (Knight et al., 2005) .
Proponents of GM crops point to the advantage to farmers of cultivating GM crops as well as positive outcomes for consumers. GM provides tools to silence or introduce specific genes that directly affect different biological processes, such as ripening and ability to withstand varying environmental circumstances. GM products have been manipulated to increase protein, starch and oil composition, and micronutrient content, thereby making these products more nutritious for consumers. Carotenoids have been introduced in some GM crops. Carotenoids are a class of minerals common in many vegetables that may help reduce risks for certain diseases and cancers (Falk et al., 2002) . Bakshi (2003) estimates that 350,000 people per year go blind due to inadequate food supplies and poor nutrition. GM crops may help alleviate this and other problems. Considerable research examines the risks versus benefits of GM crops. Furthermore, regulation of plant biotechnology is considerably more rigorous than in past years. According to Kuiper et al. (2001) , a commonly practiced safety assessment is based on 'the concept of substantial equivalence,' in which a GM product is compared to its original counterpart. Researchers are able to quickly identify changes, both positive and negative. As a result of this safety-related assessment and increasing public knowledge of GM science, some predict increased cultivation and consumption of GM products in future years.
GMO food product outcomes
While public opposition to GMOs continues, scientific research has shown that GM crops make a highly valuable contribution to sustainable agriculture, with no observed negative consequences. According to Blancke e al. (2015) , the inconsistency between negative public opinion and the positive scientific evidence supporting GM crops is subject at least partly to misrepresentations of GMOs. The researchers explain how the interplay of certain intuitions leads to the popularity, persistence, and typical aspects of GM opposition. In their study, they state that "intuitive judgments steer people away from sustainable solutions" (Blancke e al., 2015) .
The genetically modified (GM) FLAVR SAVR tomato was introduced to the market in 1994. From years 1996 to 1999 clearly labeled GM tomato paste was successfully sold in Safeway and Sainsbury supermarkets. Since that time, GM crops and food have become the center of public controversy. By 2013, GM crops were grown on more than 175 million hectares globally, by millions of farmers, many in developing countries. Use of GM crops is the fastest growing technology ever adopted by farmers in the history of agriculture. Following a large-scale study that found no impact of GM feedstuffs on livestock populations, one researcher declared that the debate about GMO safety had come to an end. While this may be true among scientists, the public continues to debate whether GM crops are damaging to the environment or detrimental to farmers (Gruissem, 2015) .
In a recent meta-analysis of all the relevant literature since 1995, findings indicated that production of GM crops reduces chemical pesticide input by 37%, increases crop yields by 22%, and increases farmers' profits by 68% on average. The authors focused on herbicide-tolerant and insect-resistant crops (maize, soybean, cotton) for which a large number of original peer-reviewed impact study reports were already available and that have also been discussed widely in the non-peer reviewed literature. The accumulated land area planted with GM crops represents an agricultural production area more than 150% of the size of the USA or China. The positive impact of GM crops increasing yield means that GM crops can produce more on a smaller area of land. Thus, there are considerable advantages of GM crops for both the environment as well as the economic well-being of farmers (Gruissem, 2015) .
Given the importance of rice as staple crop for much of the world's poorest people, GM varieties of rice will have major implications for alleviation of poverty, hunger, and malnutrition. Rice is the key food crop of the developing world and the staple food for more than half the world's population. More than 3.5 billion people rely on rice for more than 20% of their daily calorie intake. The desire to increase yields, improve disease resistance and lower the cost of rice production, along with providing nutritionally enhanced rice, are strong motivations for creating genetically engineered varieties. Similar to other GM crops, such as soybeans, maize, canola and cotton, agronomic traits such as herbicide-tolerance (HT) and insect-resistance (IR) are factors in R&D and commercialisation efforts for GM rice (Demont and Stein, 2013) .
Herbicide-tolerant GM rice can be expected to boost yields where no or little herbicide is used. The most well-known GM rice crop is provitamin A-rich 'golden rice,' which is especially beneficial in developing countries suffering from vitamin A deficiency (VAD). VAD is connected to serious health problems, including loss of sight and diminished ability to fight infections. Lactoferrin enrichment is another developing trait to go into GM rice, which helps to reduce diarrhea in high-risk patients. Studies have shown that golden rice can potentially control VAD and at a very low cost. A study found that breeding and dissemination of golden rice in India was successful, and that the crop could reduce the VAD by 60% and annually prevent the loss of 1.4 million healthy life years, also known as 'disability-adjusted life years' or DALYs. Even in a 'low impact' scenario, at US$20 per DALY saved; golden rice still represents a very cost-effective alternative to other VA fortification or supplementation (Demont and Stein, 2013) .
Part of the controversy surrounding GMOs includes human health and environmental concerns. While nations, such as those in the European Union, are able to adequately produce agricultural products without GM products, there are other nations, notably those less developed, that are facing extreme difficulty providing an adequate and stable food supply for their national economy and citizen consumption. Cohen and Paarlberg (2004) stated, "biotechnology applications provide potential contributions to sustainable agricultural productivity and new inputs for poor and/or small scale farmers in developing countries" (p.1563). Given the dire need of many people, both economic-and health-related, there is great need to evaluate and, where appropriate, implement use of GM products. Andrew Natsios, head of USAID, has argued that a lack of moving forward puts millions of lives at risk (Zerbe, 2004) .
The need for a more efficient means of agricultural production for both an economic and human welfare advantage has not gone unnoticed across the world, and some nations and institutions are making steps to help bridge the productivity gap between developed and less-developed nations. "developing countries now account for 38% of global transgenic crop area", according to Raney (2006, p.174 ). Raney identified national institutional capacity, research, and policy as key components to reaping benefits from biotechnological advancements in developing nations.
The International Rice Research Institute (IRRI) located at the University of the Philippines in Los Baños, works to reduce poverty and hunger, advance the health of rice farmers and consumers, and safeguard environmental sustainability of rice farming. The IRRI engages in collaborative research and strengthening national agricultural research and extension systems in countries where IRRI works. The IRRI is working to develop golden rice as a new food-based approach to improve vitamin A status (IRRI, 2015) .
A study by Aerni and Bernauer (2006) found that the general populations of some developing countries (i.e., Mexico, Philippines, and South Africa) see GM products as positive and a potential solution to productivity issues. This contrasts with an earlier study by Zerbe (2004) that identified considerable debate regarding use of GM technology on an international scale. Positive outcomes were identified in a study by Thirtle et al. (2003) , in which stakeholders who adopted Bt cotton in KwaZulu-Natal, South Africa were more efficient in production.
Research by Raney (2006) highlighted several cases in which GM crops were shown to be beneficial for those who adopted them. According to Raney two small-sized farmers in China using GM cotton had a net income over twice as much as that of larger-scale farms that did not adopt the GM cotton. Raney also noted Argentinian farmers who used the same GM variety of cotton received similar benefits, as well as receiving a 10% increase in productivity on average using transgenetic soybeans. In addition, Raney also noted an estimated 83% economic gain in Mexico, 80% benefit in India, and advantages (i.e., yield, pesticide, income) in KwaZulu-Natal by using the same GM cotton variety.
GMOs and diet
While there have been numerous studies of the importance of a nutritious diet, there have been relatively few specifically about GMO-free diets. Some prior studies have examined the value of a vegetarian diet, but such studies did not distinguish whether the vegetables were GMO foods or GMO-free, such as the study by Fraser et al. (2003) that found that longevity was associated with a vegetarian diet. At the same time, diet is only one part of a healthy lifestyle, whether diet includes GMO foods or not; being physically, mentally, and spiritually active have also been identified as important factors associated with overall well-being (Martin et al., 2016) .
Consuming a healthy diet has been a concern from the dawn of history. In ancient Egypt, health benefits of eating certain foods to sustain health were known long before vitamins were identified. The ancient Egyptians found that consuming liver would aid in curing night blindness, an illness now recognised to be the result of VAD (Per Ankh, 2005) . According to the ancient Greeks, the feasts of the Persians were morally depraved. The Greeks regarded gluttony as barbaric. They placed high esteem on frugality in their dining and drinking. The Greek views on food and health persisted until the end of the Middle Ages (Cook's Info, 2015) . The biblical account of Daniel, written about 540 B.C., describes the benefits of consuming healthy food. Daniel along with his three Hebrew friends decided not to eat the rich Babylonian food, but instead to dine on vegetables and water. The consequence was that "they looked healthier and better nourished than any of the young men who ate the royal food" (Daniel 1:15, cited in Martin et al., 2016) .
One alternative to GMO foods is 'organic' foods. The US Department of Agriculture indicates that for produce to be labelled organic, the produce must be grown without pesticides, synthetic fertilisers, or GMOs. For meat to be labelled organic, the animal must be raised in a natural setting, fed 100% organic feed, and not receive any antibiotics or hormones. In the case of packaged foods, if the label indicates '100%' organic, then the product was made only with organic ingredients. However, if the label indicates 'organic', then that means that only 95 percent of the ingredients are organic. For products that are labelled 'made with organic ingredients', a minimum of 70 percent of the ingredients must be organic (Lazarus, 2015) .
Consumer Reports indicates that organic foods and beverages cost an average of 47% more in price than conventional alternatives, with some costing more than 300% more. The question consumers' face is whether that markup is worth the cost. According to researchers at the Mayo Clinic, organically and conventionally produced foodstuffs are not significantly different in their nutrition value. Lisa Herzig, an associate professor of nutrition at Fresno State, states, "buying organic does not necessarily mean there's more health and nutrition benefits. The pesticide content will be higher with conventional produce, but it's still at safe levels" (Lazarus, 2015) .
Sample selection: major corporations associated with GMO food products
The sample of 30 major publicly traded companies connected to GMO food products were selected based on financial news sources and company websites. The GMO companies, along with ticker symbol and headquarters location, are shown in Table 1 . 
Methodology, analysis and results
To evaluate the economic and financial health of the 30 major companies associated with GMO food products, the following financial ratios will be evaluated: P/E ratio, profit margin, D/E, and ROE. The ratios for the GMO companies will be compared to the ratios of the top 15 industries, as measured by market capitalisation (Yahoo, 2015) .
The P/E ratio shows the relationship between a company's market price per share of stock and its net income per share, also referred to as its earnings per share (EPS). The P/E ratio indicates how many years it would take for a company's annual EPS to add up to the price of the company's stock price. The formula is as follows: The ROE ratio shows how profitable a corporation's stockholders' equity is in generating revenue. The ROE ratio provides investors (stockholders) an indication of how well their investment is performing. The formula is as follows:
ROE Net Income Average Total Stockholders' Equity =
The average financial ratios for the top 15 industries are shown in Table 2 . The P/E ratio ranged from a low of 4.8 to a high of 34.2, with an average of 19.6. The average profit margin was 10.5%. The D/E ratio ranged from a low of 29.9% to a high of 270.5%, with an average of 107%. The average ROE was 16.4%. Source: Yahoo (2015) Table 3 provides the P/E ratio for the selected 30 major companies associated with GMO food products. The P/E ratio ranged from a low of 13 to a high of 61. The average P/E ratio for the GMO companies was 26.7. This was greater than the average P/E ratio for the top 15 major industries by market capitalisation. The top 15 industries' average P/E was 19.6. The average P/E ratio for the GMO companies and the average P/E ratio for the top 15 industries were significantly different (p < .032). Table 4 shows the profit margin for the selected 30 major companies associated with GMO food products. The profit margin ranged from a low of 0.1 percent to a high of 32.4 percent. The top 15 industries had an average profit margin of 10.5%. The average profit margin for the GMO companies and the profit margin for the top 15 industries were not significantly different. Average for GMO companies 9.9
Top 15 industry average 10.5
Notes: T-test results: t = 0.30, significance p < .765. Table 5 shows the D/E ratio for the selected 30 major companies associated with GMO food products. The D/E ratio ranged from a low of 49.6% to a high of 583.9%. The average D/E ratio for the GMO companies was 183.0%. This was greater than the average D/E ratio for the top 15 major industries by market capitalisation, which had an average D/E ratio of 107.0%. The average D/E ratio for the GMO companies and the ratio for the top 15 industries were significantly different (p < .004). Table 6 shows the ROE ratio for the selected 30 major companies associated with GMO food products. The ROE ratio ranged from a low of 0.2 percent to a high of 151.8%. The average ROE ratio for the GMO companies was 27.7%. This was higher than the average ROE ratio for the top 15 major industries by market capitalisation, which had an average ROE of 16.4%. The average ROE ratio for the GMO companies and the ratio for the top 15 industries were significantly different (p < .055). A summary of the results of the analysis of the financial ratios is shown in Table 7 . The average P/E ratio for the 30 GMO companies was 26.7, which was higher than the major industries' average P/E ratio of 19.6. The difference was significant. This shows that an investor had to pay a higher average price, relative to its EPS, for a share of stock in a GMO company than for a share of stock in an average company in the top 15 industries. Thus, it would take more years for the earnings of the average GMO company to add up to the price paid for a share of stock. In general, stocks with higher P/E ratios are categorised as growth stocks. Investors pay more, relative to the stock's EPS, because of the potential and expectations of future growth in earnings. The average profit margin was about the same for the top 15 industries, 10.5%, as for the GMO companies, 9.9%. The average D/E ratio was 183.0% for the GMO companies and 107.0% for the top 15 industries. The D/E ratio was significantly higher, indicating a higher level of riskiness for GMO companies. The average ROE was 27.7% for the GMO companies and 16.4% for the top 15 industries. GMO companies provided a significantly higher ROE. 
Summary and conclusions
The first research question concerned the economic and financial performance of companies associated with GMO food products, as compared to companies in top 15 industries. Regarding financial and economic performance, GMO companies had higher averages on two of the four measures of performance (financial ratios), specifically, P/E ratio and ROE. Regarding the other two measures, compared to the top 15 industries, GMO companies had about the same profit margin and had a higher level of riskiness, as measured by the D/E ratio. Investors appear to have responded to the higher average ROE of GMO companies by paying a higher price per share relative to EPS. This indicates that investors hold a positive future outlook for GMO companies. The second research question concerned the extent that GMO foods have been affected by the positive and negative perspectives expressed about GMOs. While there will continue to be much discussion and debate, GM research and technology appears to be the most effective way to feed many of the world's hungry, notably in developing countries in Africa, Asia, and Latin America. Numerous scientific studies affirm the safety and nutritional benefits of GMO food products. However, concerns expressed by GMO opponents have been effective in limiting GMO acceptance by the public. Research indicates that the inconsistency between negative public opinion and the positive scientific evidence supporting GM crops is at least partly the result of misrepresentations of GMOs.
While much research has already been done, additional research can lead to better understanding of the benefits and potential negatives of genetic modification and biotechnology. With additional research and information dissemination, the GMO food products controversy might eventually come to an end. At this time, the future prospects for GMO companies appear positive, at least according to investors, suggesting a belief that future contributions to society by GMO companies will outweigh negative concerns. In the end, acceptance or rejection of GMO foods will have a major impact on food producers, distributors, retailers, and, particularly, consumers.
Limitations and future research
The current study was limited by the sample of companies included in the analysis and by the time period examined. Future studies could include a different sample of companies and include other time periods. This study provides a benchmark for future studies that evaluate the economic and financial performance of companies associated with GMO food products. With regard to GMO foods, this study described some of the benefits of GMOs, such as improvements to people's health and increases in food production, along with concerns about potential negative consequences.
